KNOXVILLE, Tenn.--(BUSINESS WIRE)--Provectus Pharmaceuticals, Inc. (OTC BB: PVCT), a development-stage oncology and dermatology biopharmaceutical company, announced today that Professor John F. Thompson, MD, the global Lead Investigator for its Phase 2 melanoma study, will present clinical data on PV-10 at the Sixth International Symposium on Melanoma and Other Cutaneous Malignancies on March 13, 2009, in New York City.
